drugset / Trial / NCT05197062
A Study of 14C JNJ-67953964 in Healthy Adult Male Participants
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the pharmacokinetic (PK), metabolism, and routes of excretion of aticaprant and its metabolites in excreta and in plasma after a single oral dose 14C-aticaprant in healthy adult male participants.
Timeline
- Start
- 2022-01-14
- Primary completion
- 2022-03-02
- Completion
- 2022-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aticaprant | Small molecule | — | Oral |
Indications
No indication recorded.